A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NCT06492720 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Resistant Epilepsy
Epilepsy
Epilepsy, Temporal Lobe
Seizures, Focal

Interventions

DEVICE: Focused ultrasound (FUS) treatment

Sponsor

NaviFUS Corporation